Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - UNIVERSAL BIOSENSORS INC | ex_207198.htm |
| EX-31.1 - EXHIBIT 31.1 - UNIVERSAL BIOSENSORS INC | ex_207197.htm |
| 10-Q - FORM 10-Q - UNIVERSAL BIOSENSORS INC | ubi20201016_10q.htm |
Exhibit 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 *
In connection with the quarterly report of Universal Biosensors, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company does hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of such officer’s knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. The undersigned have executed this Certificate as of the 29th day of October 2020. |
|
|
/s/ John Sharman |
|
|||||
|
|
John Sharman |
|
|||||
|
|
Principal Executive Officer |
|
|||||
|
|
|||||||
|
|
|
|
|||||
|
|
/s/ Salesh Balak |
|
|||||
|
|
Salesh Balak |
|
|||||
|
|
Principal Financial Officer |
|
|||||
|
* |
This certification is being furnished as required by Rule 13a-14(b) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code, and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent such certification is explicitly incorporated by reference in such filing. |